Caspases: potential targets for regulating cell death

被引:178
作者
Philchenkov, A [1 ]
机构
[1] Natl Acad Sci Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Mech Leukemogensis Lab, UA-03022 Kiev, Ukraine
关键词
apoptosis; caspase; death receptor; mitochondria; cytochrome c; Bcl-2; apoptosome; DISC; PIDDosome; IAP; endoplasmic reticulum; caspase inhibitor; caspase activator; therapy;
D O I
10.1111/j.1582-4934.2004.tb00468.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
While in multicellular organisms all cells inexorably die, there are several different ways provided for the realization of cell death. One of them, apoptosis, represents a universal energy-dependent and tightly regulated physiologic process of cell death in both normal and pathologic tissues. The execution of apoptosis appears to be uniformly mediated through consecutive activation of the members of a caspase family. This review briefly summarizes current knowledge on the molecular mechanisms of caspase activation and the inhibitory components of caspase cascades. The suitability of caspases as a new potential therapeutic target is discussed next. Particular attention is focused on two broad categories of caspase-directed compounds: highly specific caspase inhibitors that distinctly block the progress of apoptosis and caspase activators that selectively induce cell death in a variety of in vitro and in vivo systems. These agents promise to be useful clinically, either alone or in combination with more conventional therapeutics.
引用
收藏
页码:432 / 444
页数:13
相关论文
共 53 条
[1]   Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma [J].
Ansell, SM ;
Arendt, BK ;
Grote, DM ;
Jelinek, DF ;
Novak, AJ ;
Wellik, LE ;
Remstein, ED ;
Bennett, CF ;
Fielding, A .
LEUKEMIA, 2004, 18 (03) :616-623
[2]  
BLACK RA, 1989, J BIOL CHEM, V264, P5323
[3]   Apoptosis in disease: about shortage and excess [J].
Brunner, T ;
Mueller, C .
PROGRAMMED CELL DEATH, 2003, 39 :119-130
[4]   RGD peptides induce apoptosis by direct caspase-3 activation [J].
Buckley, CD ;
Pilling, D ;
Henriquez, NV ;
Parsonage, G ;
Threlfall, K ;
Scheel-Toellner, D ;
Simmons, DL ;
Albar, AN ;
Lord, JM ;
Salmon, M .
NATURE, 1999, 397 (6719) :534-539
[5]   Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction [J].
Chandrashekhar, Y ;
Sen, S ;
Anway, R ;
Shuros, A ;
Arland, I .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (02) :295-301
[6]   Oligomerization is a general mechanism for the activation of apoptosis initiator and inflammatory procaspases [J].
Chang, DW ;
Ditsworth, D ;
Liu, HT ;
Srinivasula, SM ;
Alnemri, ES ;
Yang, XL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) :16466-16469
[7]   The Bcl-2 family: roles in cell survival and oncogenesis [J].
Cory, S ;
Huang, DCS ;
Adams, JM .
ONCOGENE, 2003, 22 (53) :8590-8607
[8]   Apoptosis in human disease: A new skin for the old ceremony? [J].
Fadeel, B ;
Orrenius, S ;
Zhivotovsky, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 266 (03) :699-717
[9]   Organelle-specific initiation of cell death pathways [J].
Ferri, KF ;
Kroemer, G .
NATURE CELL BIOLOGY, 2001, 3 (11) :E255-E263
[10]   Protein-based therapeutic approaches targeting death receptors [J].
French, LE ;
Tschopp, J .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (01) :117-123